Literature DB >> 19226377

Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.

Geoffrey C Farrell1, Claire Z Larter, Jing Yun Hou, Rena H Zhang, Matthew M Yeh, Jacqueline Williams, Aileen dela Pena, Rona Francisco, Sarah R Osvath, John Brooling, Narcissus Teoh, Lisa M Sedger.   

Abstract

BACKGROUND AND AIMS: We examined extrinsic and intrinsic (endogenous) mitochondrial apoptosis pathways in experimental non-alcoholic steatohepatitis (NASH).
METHODS: To assess extrinsic pathways, we measured hepatic expression of death-inducing cytokine receptors (tumor necrosis factor-alpha-receptor (TNF-R)1, TNF-R2, Fas, and TNFalpha-related apoptosis-inducing ligand-receptor (TRAIL-R) mRNA, TUNEL, caspase 3 activation, liver injury and liver pathology in mice fed a methionine and choline deficient (MCD) diet. For endogenous stress pathways, we determined serum insulin-like growth factor-1 (IGF-1), hepatic p53, Bcl-XL, tBid and p21 expression.
RESULTS: Methionine and choline deficient feeding increased alanine aminotransferase (ALT) and apoptosis from day 10, without increases in TNF-R1, TNF-R2, and Fas. However, murine TRAIL receptors, particularly decoyTRAIL-R1/TNFRSFH23 and Killer/DR5 mRNA increased. MCD feeding enhanced hepatic p53 expression, corresponding to approximately 50% fall in serum IGF-1, decreased Bcl-XL, enhanced Bid cleavage to tBid, and up-regulation of p21. Nutritional restitution experiments showed that correcting either methionine or choline deficiency suppressed liver inflammation (extrinsic pathway), but failed to correct apoptosis, IGF-1 or p53.
CONCLUSIONS: Methionine and choline deficiency lower IGF-1 to de-repress p53 during induction of steatohepatitis. The p53 induced by nutritional stress is biologically active in mediating mitochondrial cell death pathways, but may also be responsible for TRAIL receptor expression, thereby linking intrinsic and exogenous apoptosis pathways in NASH.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19226377     DOI: 10.1111/j.1440-1746.2009.05785.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  53 in total

1.  The p53 Codon 72 Polymorphism Modifies the Cellular Response to Inflammatory Challenge in the Liver.

Authors:  Julia I-Ju Leu; Maureen E Murphy; Donna L George
Journal:  J Liver       Date:  2013

2.  A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis.

Authors:  Vlad Ratziu; Muhammad Y Sheikh; Arun J Sanyal; Joseph K Lim; Hari Conjeevaram; Naga Chalasani; Manal Abdelmalek; Anezi Bakken; Christophe Renou; Melissa Palmer; Robert A Levine; B Raj Bhandari; Melanie Cornpropst; Wei Liang; Benjamin King; Elsa Mondou; Franck S Rousseau; John McHutchison; Mario Chojkier
Journal:  Hepatology       Date:  2011-12-14       Impact factor: 17.425

3.  Increased hepatic apoptosis in high-fat diet-induced NASH in rats may be associated with downregulation of hepatic stimulator substance.

Authors:  Ying Jiang; Miaoyun Zhao; Wei An
Journal:  J Mol Med (Berl)       Date:  2011-08-04       Impact factor: 4.599

4.  Dietary methyl deficiency, microRNA expression and susceptibility to liver carcinogenesis.

Authors:  Athena Starlard-Davenport; Volodymyr Tryndyak; Oksana Kosyk; Sharon R Ross; Ivan Rusyn; Frederick A Beland; Igor P Pogribny
Journal:  J Nutrigenet Nutrigenomics       Date:  2011-04-06

Review 5.  The role of MDM2-p53 axis dysfunction in the hepatocellular carcinoma transformation.

Authors:  Hui Cao; Xiaosong Chen; Zhijun Wang; Lei Wang; Qiang Xia; Wei Zhang
Journal:  Cell Death Discov       Date:  2020-06-19

6.  Death receptor 5 signaling promotes hepatocyte lipoapoptosis.

Authors:  Sophie C Cazanave; Justin L Mott; Steven F Bronk; Nathan W Werneburg; Christian D Fingas; X Wei Meng; Niklas Finnberg; Wafik S El-Deiry; Scott H Kaufmann; Gregory J Gores
Journal:  J Biol Chem       Date:  2011-09-22       Impact factor: 5.157

7.  Dietary methyl deficiency, microRNA expression and susceptibility to liver carcinogenesis.

Authors:  Athena Starlard-Davenport; Volodymyr Tryndyak; Oksana Kosyk; Sharon R Ross; Ivan Rusyn; Frederick A Beland; Igor P Pogribny
Journal:  World Rev Nutr Diet       Date:  2010-04-30       Impact factor: 0.575

Review 8.  New insights from rodent models of fatty liver disease.

Authors:  Jacquelyn J Maher
Journal:  Antioxid Redox Signal       Date:  2011-04-26       Impact factor: 8.401

9.  Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice.

Authors:  Justin R Henning; Christopher S Graffeo; Adeel Rehman; Nina C Fallon; Constantinos P Zambirinis; Atsuo Ochi; Rocky Barilla; Mohsin Jamal; Michael Deutsch; Stephanie Greco; Melvin Ego-Osuala; Usama Bin-Saeed; Raghavendra S Rao; Sana Badar; Juan P Quesada; Devrim Acehan; George Miller
Journal:  Hepatology       Date:  2013-06-24       Impact factor: 17.425

10.  Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease.

Authors:  Zoltan Derdak; Kristine A Villegas; Ragheb Harb; Annie M Wu; Aryanna Sousa; Jack R Wands
Journal:  J Hepatol       Date:  2012-12-02       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.